Transfusion transmission of West Nile virus: A merging of historical and contemporary perspectives

Transfusion

Volumn 43, Issue 8, 2003, Pages 992-997

  Hollinger, F Blaine ^a   Kleinman, Steven ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

BLOOD DONOR; BLOOD TRANSFUSION; EVIDENCE BASED MEDICINE; EXPERIMENTAL INFECTION; HEALTH CARE POLICY; HISTORY; HUMAN; INFECTION RISK; MENINGOENCEPHALITIS; MOSQUITO; NONHUMAN; REVIEW; SCREENING TEST; UNITED STATES; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANIMALS; BLOOD TRANSFUSION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PREVENTIVE MEDICINE; WEST NILE FEVER;

EID: 0042430606     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00501.x     Document Type: Review

References (24)

1. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940;20:471-92.
2. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a house-hold-based seroepidemiological survey. Lancet 2001; 358:261-4.
3. Serosurveys for West Nile virus infection - New York and Connecticut counties, 2000. Morb Mortal Wkly Rep 2001;50:37-9.
4. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November, 2002. Morb Mortal Wkly Rep 2002;51:1129-33.
5. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998;352:767-71.
6. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002;137:173-9.
7. Tsai TF. Flaviviruses (yellow fever, dengue, dengue hemorrhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone; 2000:1714-36.
8. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002;2:519-29.
9. Southam CH, Moore AE. West Nile, Ilheus, and Bunyamwera virus infections in man. Am J Trop Med 1951;31: 724-41.
10. Southam CH, Moore AE. Induced virus infections in man by the Egypt isolate of West Nile Virus. Am J Trop Med 1954;3:19-50.
11. Melnick JL, Paul JR, Riordan JT, et al. Isolation from human sera in Egypt of a virus apparently identical to West Nile virus. Proc Soc Exp Biol Med 1951;77:661-5.
12. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002;42: 1019-26.
13. Public Health dispatch: West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002. Morb Mortal Wkly Rep 2002;51:790.
14. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. Morb Mortal Wkly Rep 2002;51:833-6.
15. Public health dispatch: investigations of West Nile virus infections in recipients of blood transfusions. Morb Mortal Wkly Rep 2002;51:973-4.
16. Laboratory-acquired West Nile virus infections - United States, 2002. Morb Mortal Wkly Rep 2002;51:1133-5.
17. Intrauterine West Nile virus infection - New York, 2002. Morb Mortal Wlkly Rep 2002;51:1135-6.
18. Possible West Nile virus transmission to an infant through breast feeding - Michigan, 2002. Morb Mortal Wkly Rep 2002;51:877-8.
19. Biggerstaff B, Petersen L. Estimated risk of West Nile virus transmission through blood transfusion in the United States, 2002. Transfusion 2003;43:1007-17.
20. Center for Biologics Evaluation and Research. Final guidance for industry: recommendations for the assessment of donor suitability and blood and blood products safety in cases of known or suspected West Nile virus infection (Internet). Rockville (MD): The Center; 2002 Oct 25. Available from: http://www.fda.gov/cber/guidelines.htm
21. FDA news: FDA statement on blood industry's voluntary market withdrawal of certain frozen blood products to reduce risk of West Nile virus transmission from transfusion. Washington: FDA; 2002 Dec 12.
22. Krugman S, Ward R, Giles JP, et al. Infectious hepatitis detection of virus during the incubation period and in clinically inapparent infection. N Engl J Med 1959;261: 729-34.
23. Hollinger FB, Emerson SU. Hepatitis A virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2001:799-840.
24. Center for Biologics Evaluation and Research. Workshop on development of donor screening assays for West Nile Virus. Rockville (MD): The Center; 2002 Nov 4-5.